SGK1 and Parkinson disease: Increased S100a6 expression has been observed in AD and ALS (Filipek and Leśniak, 2020), while Sgk1 upregulation has been associated with DA neuron death in rodent toxin models of PD (Iwata et al., 2004; Stichel et al., 2005).